default author photo

Gwenaëlle Gravis

Institut Paoli-Calmettes

SCHOLARLY PAPERS

5

DOWNLOADS

226

TOTAL CITATIONS

1

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

The GETUG SEMITEP Trial: De-Escalating Chemotherapy in Good-Risk Metastatic Seminoma Based on Early FDG-PET/CT

Number of pages: 25 Posted: 16 Dec 2020
Yohann Loriot, Matthieu Texier, Stéphane Culine, Aude Flechon, Antoine Thierry-Vuillemin, Gwenaëlle Gravis, Lionel Geoffrois, Christine Chevreau, Marine Gross-Goupil, Philippe Barthelemy, Emmanuelle Bompas, Hakim Mahammedi, Brigitte Laguerre, Sophie Abadie-Lacourtoisie, Carole Helissey, Sylvain Ladoire, Christine Abraham, Christophe Massard, Serena Grimaldi and Karim Fizazi
Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Department of Medical Oncology, Saint-Louis-APHP, Faculté de Paris, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Service d'Oncologie Médicale, CHU Besançon, Institut Paoli-Calmettes, Medical Oncology, Institute of Cancerology of Lorraine - Alexis Vautrin, Institut Claudius Régaud IUCT Toulouse, Centre hospitalo-Universitaire, Bordeaux, Medical Oncology, Hôpitaux Universitaires de Strasbourg, Institut de Cancérologie de l'Ouest, Centre Jean Perrin, Centre Eugène Marquis - Department of Medical Oncology, Western Cancer Institute, Clinical Research Unit, Military Hospital Begin, Department of Medical Oncology, Centre Georges-François Leclerc, Department of Medical Oncology, Centre Hospitalier Versailles André Mignot, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy, Department of Nuclear Medicine and Endocrine Oncology, Université Paris-Saclay and Université Paris XI Sud - Gustave Roussy Cancer Campus
Downloads 79 (809,932)
Citation 1

Abstract:

Loading...

2.

Gemcitabine Plus Platinum-Based Chemotherapy in Combination with Bevacizumab for Kidney Metastatic Collecting Duct and Medullary Carcinomas: Results of a Prospective Phase II Trial (BEVABEL- GETUG/AFU24)

Number of pages: 22 Posted: 28 Feb 2023
Constance Thibault, Aude Flechon, Laurence ALBIGES, Charlotte JOLY, Philippe Barthelemy, Marine Gross-Goupil, Christine Chevreau, Elodie Coquan, Frédéric Rolland, Brigitte Laguerre, Gwenaëlle Gravis, Nicolas Pecuchet, Rea-Thierry Elaidi, Marc-Olivier Timsit, Meryem Brihoum, Edouard AUCLIN, Aurélien De Reynies, Yves Allory and Stéphane Oudard
Université Paris Cité, University of Claude Bernard Lyon 1 - Centre Léon Bérard, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris - Hôpital Henri-Mondor, Institut de cancérologie Strasbourg Europe (ICANS), Centre hospitalo-Universitaire, Bordeaux, Institut Claudius Régaud IUCT Toulouse, Centre François Baclesse - Department of Medical Oncology, René Gauducheau, Centre Eugène Marquis - Department of Medical Oncology, Institut Paoli-Calmettes, Hôpital d'Instruction des Armées Bégin, ARTIC: Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie, Université Paris Cité, UNICANCER, Université Paris Cité, Université Paris Cité, University of Paris-Saclay and Université Paris Cité
Downloads 45 (1,121,190)

Abstract:

Loading...

Adult, rare tumors, renal medullary carcinoma (RMC), collecting duct carcinoma, bevacizumab, chemotherapy

3.

Gastrointestinal Metastases in Renal Cell Carcinoma: A Retrospective Multicenter GETUG (Groupe D’Étude Des Tumeurs Uro-Génitales) Study

Number of pages: 17 Posted: 28 Nov 2023
Florian Carneiro, Armelle Vinceneux, Mathieu Larroquette, Maelle Rony, Lucia Carril, Brigitte Laguerre, Ilfad Blazevic, Philippe Barthelemy, Diego Teyssonneau, Morgan Goujon, Claude Linassier, Antoine Thierry-Vuillemin, Guilhem Roubaud, Loic Mourey, Laurence ALBIGES, Gwenaëlle Gravis, Marine Gross-Goupil and Mathilde Cancel
University Hospital of Tours, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Bordeaux University Hospital, Institut Paoli-Calmettes, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Centre Eugène Marquis - Department of Medical Oncology, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Institut de cancérologie Strasbourg Europe (ICANS), Bergonié Institute, Jean Minjoz Hospital, University Hospital of Tours, Service d'Oncologie Médicale, CHU Besançon, Bergonié Institute, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, University of Paris-Saclay, Institut Paoli-Calmettes, Centre hospitalo-Universitaire, Bordeaux and University Hospital of Tours
Downloads 42 (1,157,785)

Abstract:

Loading...

Renal Cell Carcinoma, Gastrointestinal Tract, Metastasis, Gastrointestinal Hemorrhage

4.

Survival modelling of relapse-free survival and competing-risk analysis in patients with high-risk localized prostate cancer treated in GETUG-12

Number of pages: 27 Posted: 23 Jan 2026
Cécile Vicier, Farah Erdogan, Nedjla Allouache, Remy Delva, Gwenaëlle Gravis, Frédéric Rolland, Frank Priou, Jean-Marc FERRERO, Nadine Houede, Loic Mourey, Christine Theodore, Ivan Krakowski, Jean-François Berdah, Marjorie Baciuchka, Brigitte Laguerre, Aude Flechon, Marine Gross-Goupil, Isabelle Cojean-Zelek, Stéphane Oudard, jean-luc labourey, Paule Chinet-Charrot, Eric Legouffe, Jean-Léon Lagrange, Claude Linassier, Gaël Deplanque, Philippe Beuzeboc, Jean-Louis Davin, Meryem Brihoum, Stéphane Culine, Karim Fizazi and Gwénaël Le Teuff
Aix-Marseille University - Institut Paoli-Calmettes, Gustave Roussy, UNICANCER, affiliation not provided to SSRN, Institut Paoli-Calmettes, René Gauducheau, affiliation not provided to SSRN, Centre François Baclesse, CHU Nimes, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, affiliation not provided to SSRN, Centre Alexis Vautrin, affiliation not provided to SSRN, affiliation not provided to SSRN, Centre Eugène Marquis - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Centre hospitalo-Universitaire, Bordeaux, affiliation not provided to SSRN, Université Paris Cité, affiliation not provided to SSRN, Centre Henri Becquerel, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, École Normale Supérieure - PSL Research University - Institut Curie, affiliation not provided to SSRN, UNICANCER, Department of Medical Oncology, Saint-Louis-APHP, Faculté de Paris, University of Lille II - Centre Oscar Lambret and Université Paris XI Sud - Unité de Biostatistiques et d'Épidémiologie
Downloads 31 (1,304,549)

Abstract:

Loading...

High-risk localized prostate cancer, GETUG-12, Relapse-free survival, Biochemical progression, Survival modelling

5.

PD-L1 Expression and its Prognostic Value in Metastatic Papillary Renal Cell Carcinoma: Results from a GETUG Multicenter Retrospective Cohort

Number of pages: 19 Posted: 19 Mar 2024
Jérémie Naffrichoux, Pierre Poupin, William Pouillot, Claude Linassier, Nathalie Rioux-Leclercq, Manon De Vries-Brilland, Loic Mourey, Brigitte Laguerre, Stéphane Oudard, Marine Gross-Goupil, Coralie Mousset, Gwenaëlle Gravis, Frédéric Rolland, Laura Moise, Sheik Emambux, Cécile Vassal, Sylvie Zanetta, Nicolas Penel, Laurence ALBIGES, Gaelle Fromont and Mathilde Cancel
University of Padua - University Hospital, University of Nantes, University Hospital of Tours, University Hospital of Tours, Hospital Center University Pontchaillou, Institut de Cancérologie de l'Ouest, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Centre Eugène Marquis - Department of Medical Oncology, Université Paris Cité, Centre hospitalo-Universitaire, Bordeaux, University Hospital of Tours, Institut Paoli-Calmettes, René Gauducheau, University Hospital of Tours, La Milétrie University Hospital, Institut de Cancérologie Lucien Neuwirth (ICLN), Centre Georges-François Leclerc, University of Lille II - Centre Oscar Lambret, University of Paris-Saclay, Université de Tours and University Hospital of Tours
Downloads 29 (1,332,057)

Abstract:

Loading...

papillary renal cell carcinoma, immune checkpoints, PD-L1, angiogenesis